Lopurin and Pulmonary infarction - a phase IV clinical study of FDA data

Summary:

Pulmonary infarction is reported as a side effect among people who take Lopurin (allopurinol), especially for people who are male, 60+ old, have been taking the drug for 10+ years also take Lasix, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Pulmonary infarction when taking Lopurin. It is created by eHealthMe based on reports of 188,140 people who have side effects when taking Lopurin from the FDA, and is updated regularly.

What is Lopurin?

Lopurin has active ingredients of allopurinol. It is often used in gout. eHealthMe is studying from 190,798 Lopurin users. Check the latest studies of Lopurin.

What is Pulmonary infarction?

Pulmonary infarction (death of a small area of lung) is found to be associated with 396 drugs and 621 conditions by eHealthMe. Check the latest studies of Pulmonary infarction.

On Aug, 01, 2026

188,140 people reported to have side effects when taking Lopurin.
Among them, 48 people (0.03%) have Pulmonary infarction.

Could Lopurin cause Pulmonary infarction?

Among these 48 people:

How long have people been on Lopurin when they have Pulmonary infarction? *

What is the gender of people who have Pulmonary infarction when taking Lopurin? *

female: 45.24 %
male: 54.76 %

What is the age of people who have Pulmonary infarction when taking Lopurin? *

What are other drugs people take besides Lopurin? *

What are other side effects people have besides Pulmonary infarction? *

Pulmonary Embolism (blockage of the main artery of the lung): 28 people, 58.33%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 22 people, 45.83%
Dyspnea (difficult or laboured breathing): 14 people, 29.17%
Thrombocytopenia (decrease of platelets in blood): 11 people, 22.92%
Anaemia (lack of blood): 11 people, 22.92%
Chest Pain: 11 people, 22.92%
Rashes (redness): 10 people, 20.83%
Oedema Peripheral (superficial swelling): 10 people, 20.83%
Cough: 9 people, 18.75%
Joint Pain: 9 people, 18.75%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 10 people, 20.83%
High Blood Pressure: 4 people, 8.33%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 8.33%
Primary Myelofibrosis (primary disorder of the bone marrow): 4 people, 8.33%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 4 people, 8.33%
Parophthalmia (inflammation of the connective tissue around the eye): 3 people, 6.25%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 6.25%
Herpes Zoster: 3 people, 6.25%
Castleman's Disease (a disease of lymph nodes and related tissues): 3 people, 6.25%
Acute Monocytic Leukaemia (a type of blood cancer): 2 people, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Lopurin and have Pulmonary infarction?

- Check whether Pulmonary infarction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lopurin:

Lopurin (190,798 reports)

Browse all side effects of Lopurin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary infarction:

Pulmonary infarction (396 drugs)

Browse all the conditions that are associated with Pulmonary infarction:

Pulmonary infarction (621 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on allopurinol (the active ingredients of Lopurin) and Lopurin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.